BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31095909)

  • 1. Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.
    Lee C; Guo H; Klinngam W; Janga SR; Yarber F; Peddi S; Edman MC; Tiwari N; Liu S; Louie SG; Hamm-Alvarez SF; MacKay JA
    Mol Pharm; 2019 Jul; 16(7):3024-3039. PubMed ID: 31095909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
    Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
    J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome.
    Guo H; Lee C; Shah M; Janga SR; Edman MC; Klinngam W; Hamm-Alvarez SF; MacKay JA
    J Control Release; 2018 Dec; 292():183-195. PubMed ID: 30359668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berunda Polypeptides: Multi-Headed Fusion Proteins Promote Subcutaneous Administration of Rapamycin to Breast Cancer
    Dhandhukia JP; Li Z; Peddi S; Kakan S; Mehta A; Tyrpak D; Despanie J; MacKay JA
    Theranostics; 2017; 7(16):3856-3872. PubMed ID: 29109782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.
    Ju Y; Edman MC; Guo H; Janga SR; Peddi S; Louie SG; Junge JA; MacKay JA; Hamm-Alvarez SF
    Biomacromolecules; 2021 Mar; 22(3):1102-1114. PubMed ID: 33356170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.
    Ju Y; Guo H; Yarber F; Edman MC; Peddi S; Janga SR; MacKay JA; Hamm-Alvarez SF
    Bioconjug Chem; 2019 Sep; 30(9):2358-2372. PubMed ID: 31408605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.
    Shi P; Aluri S; Lin YA; Shah M; Edman M; Dhandhukia J; Cui H; MacKay JA
    J Control Release; 2013 Nov; 171(3):330-8. PubMed ID: 23714121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
    Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
    Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.
    Guo H; Ju Y; Choi M; Edman MC; Louie SG; Hamm-Alvarez SF; MacKay JA
    Biomaterials; 2022 Apr; 283():121441. PubMed ID: 35306230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
    Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
    Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis.
    Peddi S; Pan X; MacKay JA
    Front Pharmacol; 2018; 9():1184. PubMed ID: 30386244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
    Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
    Fu R; Edman MC; Hamm-Alvarez SF
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
    Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
    Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
    Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
    Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional Elastin-like Polypeptide Nanoparticles Bind Rapamycin and Integrins and Suppress Tumor Growth in Vivo.
    Dhandhukia JP; Shi P; Peddi S; Li Z; Aluri S; Ju Y; Brill D; Wang W; Janib SM; Lin YA; Liu S; Cui H; MacKay JA
    Bioconjug Chem; 2017 Nov; 28(11):2715-2728. PubMed ID: 28937754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
    Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.